The eye nebulizer is a big leap from the standard eyedropper. It is easier to use and more effective at delivering the right amount of medication, strongly reducing the risk of serious side effects. By limiting infection and other medical complications, our solution has the potential to even save lives. Eye diseases affect billions of...

This Gantt chart illustrates the progress made and to be made with so-called advanced drug delivery systems we are currently working on, particularly but not exclusively those in the nanometre domain. Our estimated phases resulted from discussions with a number of experts in the field who shared their views on aspects of the subject.

We are extremely proud of a patent application for the system that dispenses a single drop of liquid from a container. Our research showed that the majority of the patients has difficulties while eye drops application. These difficulties cause losses in the substance, incorrect dosage or its omission due to incorrect application. Of course, there...

The result of the project will be the development of an innovative drug formulation, which could be used in ophthalmology. In the process of development, the concept of an innovative drug formulation will be implemented in accordance with our original methodology – Passio Innovation Way. Many people have experienced itchiness and a gritty, dry feeling...

The Passio Eye Nebulizer is a huge leap forward from the standard eyedroppers, which are already on the market. It is easier to use and much gentle to the eye. Most importantly, the process of eye nebulization is much more effective in delivering the right amount of medication, substantially reducing the risk of serious side...

The result of the project will be the development of an innovative ophthalmic drug dispensing system. During the project implementation, it is planned to design and develop an innovative medical device that will significantly improve the effectiveness and safety process as well as the effectiveness of ophthalmic therapy, including patient’s compliance issue. Passio worked out...